BioFocus DPI Expands Ion Channel Offering Through Agreement With ChanTest Corporation
2/6/2013 10:37:04 AM
More...
|
ChanTest Corporation Goes Beyond GLP to Become First Ion Channel and GPCR CRO With Cgmp Testing Capability
1/14/2013 9:28:33 AM
More...
|
ChanTest Corporation Announces Drug Discovery Services Using the Enamine Ltd. 3D Compound Library
10/16/2012 10:12:20 AM
More...
|
ChanTest Corporation Awarded $1 Million Grant for Predictive Assays Using Stem Cell-Derived Human Cardiomyocytes
9/18/2012 10:47:56 AM
More...
|
ChanTest Corporation Hires Chris Mathes as Chief Commercial Officer
8/17/2012 10:16:59 AM
More...
|
ChanTest Corporation Sponsors Great Strides Walk for Cystic Fibrosis
5/8/2012 10:20:43 AM
More...
|
Roche (RHHBY), ChanTest Corporation Collaborate for Preclinical Cardiac Safety Testing of Drug Compounds Using iCell Cardiomyocytes and xCELLigence RTCA Cardio Instrument
12/5/2011 7:32:13 AM
More...
|
ChanTest Corporation Signs Research Collaboration Agreement with The FDA
6/9/2011 8:50:58 AM
More...
|
ChanTest Corporation First To Offer New High Throughput Electrophysiology Platform Validated for Both VGICs and LGICs
4/6/2011 10:41:39 AM
More...
|
ChanTest Corporation and Molecular Devices Ltd (MDCC) Sign Cell Line Distribution Agreement
3/24/2011 8:06:53 AM
More...
|
|